Jabra Enhance Select 200 vs MDHearing Volt

The Jabra Enhance Select 200 is a premium-priced OTC hearing aid that earns a B grade with a SoundScore of 3.9/5 in our lab testing, ranking in the top 35% of OTC devices. At $1,695, it sits at the higher end of the OTC market and has earned HearAdvisor's Expert's Choice Award in both 2023 and 2024. This behind-the-ear device delivers its strongest performance in speech clarity during quiet environments, scoring 3.5/5—a solid result that sits 0.67 points above the OTC category average. Own-voice comfort is another highlight at 3.4/5, which is 0.89 points above average, meaning wearers are less likely to experience the bothersome "talking in a barrel" sensation. Music streaming scores 2.6/5, which is 0.68 points above the category average, though still mixed in absolute terms. The device shows some limitations in challenging listening situations. Speech in noise performance is low at 1.4/5, sitting slightly below the category average. Feedback handling scores a strong 4.0/5 in absolute terms, though this falls 0.54 points below the OTC average of 4.54/5. The Enhance Select 200 includes modern conveniences like rechargeable batteries and streaming compatibility with both iPhone and Android devices, plus hands-free calling capability. However, budget-conscious shoppers should note that several devices in this price range—including the Lucid Tala and Audicus Omni 2—achieve higher scores, and alternatives like the Lucid Engage offer similar sound quality at lower prices. This device is best suited for listeners who prioritize clear speech in quieter settings and natural own-voice quality over performance in noisy environments.

The MDHearing Volt is a budget-priced prescription hearing aid available for $397, earning a B grade with a SoundScore of 3.1/5 in our lab testing. This behind-the-ear, rechargeable device ranks #32 of 36 prescription hearing aids tested, placing it in the top 86% of its category. In our standardized testing, the Volt demonstrates excellent feedback handling at 5.0/5, scoring 0.29 points above the category average. This represents a genuine strength, as the device remained stable under our challenge protocols without audible squealing or whistling. However, speech performance presents significant limitations: speech in quiet scored 1.8/5 (1.57 points below the category average of 3.32), while speech in noise scored 1.0/5 (0.96 points below the 1.96 average). Own-voice comfort measured 2.6/5, a mixed result that falls 0.15 points below the category average. Music streaming is notably limited at 0.0/5, scoring 2.64 points below the category average—users prioritizing phone streaming should consider alternatives. The Volt showed no improvement between Initial and Tuned fits, with both configurations yielding identical scores of 3.1/5. The MDHearing Volt may suit budget-conscious consumers who prioritize basic amplification and excellent feedback stability over speech clarity or streaming features. However, shoppers in this price range should note that alternatives like the RxEars Rxi offer substantially higher performance at similar pricing.